Seven — 001

Disclaimer: SVN Research is educational commentary, not financial advice. Nothing here is a recommendation to buy or sell any security. Do your own research and consider speaking with a licensed professional before investing.

Full breakdowns below.

Before we talk about any single stock, let's check the weather — because the environment a stock trades in matters as much as the stock itself.

Rates: higher for longer. The Federal Reserve held interest rates steady at 3.50%–3.75% in June, the fourth meeting in a row with no change. But the tone shifted. Under new chair Kevin Warsh, the Fed dropped the language that used to hint at future rate cuts, and its own projections now point to a possible rate hike before year-end. Why does this matter to us? Because interest rates are the price of money. When rates stay high, future profits are worth less in today's dollars — and that hits "pay me later" stories like turnarounds hardest. Keep that in your back pocket when we get to Intel.

Inflation: still hot, mostly because of oil. May inflation came in at 4.2% year over year, the first time the headline number has crossed 4% in three years. But strip out food and energy and the "core" reading was a much calmer 2.9%. That gap tells the story: this isn't broad-based price pressure — it's an energy spike, driven by conflict in the Middle East disrupting global oil shipping.

The wildcard: geopolitics. A U.S.–Iran conflict pushed oil prices up fast by threatening the Strait of Hormuz, the waterway about a quarter of the world's seaborne oil flows through. The good news arrived mid-month: an interim peace deal reopening the Strait, which eased energy fears and gave stocks a lift. This is worth watching — the same conflict driving inflation could, if it cools, give the Fed room to breathe.

The backdrop for our stock. Despite all this, the market is sitting near record highs, and one theme is doing the heavy lifting: artificial intelligence and the semiconductors that power it. That's the exact wave Intel is riding — the stock jumped more than 10% in a single day this month on news tied to a possible Apple chip deal. So as we dig into Intel, remember the setup: a richly priced market, a chip sector running hot on AI enthusiasm, and a Fed that isn't handing out cheap money anymore. That last part will matter a lot for a company funding an expensive turnaround on borrowed money.

Intel has been in the news a lot lately, and for good reason — it just had one of the most dramatic 52-week runs I've ever seen. The stock climbed from about $19 to roughly $134 in a single year. A move like that always makes me curious: what's actually driving it? So I dug in, and the first thing you have to understand is that Intel is really two companies wearing one ticker.

The first is Intel Products — the CPUs in laptops and the server chips that power data centers. This business makes money: roughly +$12.7B in operating profit. The second is Intel Foundry — the factories that manufacture chips, both for Intel and, eventually, for outside customers. This business loses money: about −$10.3B. Intel is spending enormous sums to build leading-edge manufacturing on U.S. soil instead of outsourcing it to Taiwan's TSMC the way most chip designers do.

One investor summed it up in a line worth remembering: a profitable CPU company funding a very expensive manufacturing turnaround. The whole debate around the stock lives inside that sentence.

The bull case (why people are buying):

The bear case (why people are cautious):

So here's the dilemma. The stock has run from the high teens to over $130 in a year, largely on the hope that Foundry succeeds. If it does — if 18A works and those customer deals turn real — today's price may be reasonable because the market is paying for a much bigger future manufacturing business. If it doesn't, the profitable CPU business alone probably can't justify the whole valuation.

That's the bet the market is making at $134. The question I kept coming back to is simpler: forget what the stock is priced at — what is Intel actually worth, and what would I be willing to pay for it? That's where the rest of this issue is headed.

We know the debate now. This section answers two narrower questions: what does the chart say about timing, and what do the fundamentals say about quality? Two lenses, two timeframes.

The run is the headline — Intel went from about $19 to an all-time high near $135 in a year. After a move like that, the first thing I check is whether the stock is stretched. It is:

Price is also sitting far above all of its major moving averages, which is just another way of saying the same thing: after a 6x year, the stock is well ahead of its own trend. None of these are predictions. Together they tell me the stock is overextended and showing early signs of a bearish tilt.

One number worth understanding: the ATR is about $9.86. ATR (Average True Range) measures how much a stock typically moves in a day — so Intel swings roughly $9.86 daily, a little over 7% of its price. That's a lot. This is a high-volatility name (its beta is north of 3), and any position has to be sized for big daily moves.

The chart's verdict: near-term overextended. But technicals only describe price behavior — they say nothing about what the company is worth. That's the next lens.

Before the long-term view, here's the latest snapshot — and it's genuinely improving:

This matters, and I won't pretend otherwise: a 7% revenue quarter is the first sign of reacceleration after years of flat sales, and a near-breakeven year is real progress. But one or two good quarters is an inflection, not yet a proven turnaround. The five-year picture — the one the pillars capture — is still where the company has to prove itself.

I run every company through the same eight-pillar checklist — a framework I picked up from the Everything Money channel and have since folded into my own process. A note before the numbers: this checklist was built to evaluate stable, compounding businesses. Intel right now is a turnaround, not a compounder, so almost every pillar flags red. That's expected. The point isn't "Intel fails 8 of 8, therefore sell." The point is that Intel is currently priced like a healthy growth company while operating like one in the middle of an expensive rebuild.

The ones worth explaining:

The P/E is sky-high (or negative, depending on the day), and that's the point. P/E compares price to earnings, and Intel's earnings are in a hole from restructuring and Foundry losses. When earnings sit near zero, P/E either explodes into the hundreds or goes negative — it's not telling you the market values Intel at 890x, it's telling you P/E breaks down for a company near an earnings bottom. This is exactly why you can't value a turnaround on P/E alone.

ROIC of ~2.28% is the more honest number. ROIC (Return on Invested Capital) measures how much profit a company squeezes from the money it puts to work. Healthy compounders clear 9%+. Intel down here is earning less on its capital than that capital costs — meaning, for now, growth is destroying value rather than creating it.

Share count has gone the wrong way. Intel has grown from about 4.09 billion shares in 2021 to over 5 billion in early 2026. More shares means each one is a smaller slice of the company — picture cutting the same pizza into more slices. Healthy compounders shrink their share count; Intel has expanded its.

The last two pillars can't even be calculated because free cash flow is negative — Intel is burning cash, not generating it, so there's nothing to measure debt or price against. A company with negative FCF can't pay down debt with its own cash. That ties to one more flag: Enterprise Value sits above Market Cap, which signals debt outweighs cash on the balance sheet, largely from funding Foundry.

The fundamentals' verdict: by every measure built for a quality compounder, Intel doesn't qualify today. The recent quarter hints the bottom may be in — but "may be" is doing a lot of work, and the entire bull case rests on that improvement continuing. Which brings us to the only question that matters: what is it actually worth?

Every week this section is about the one figure that matters most. For Intel, it's not the $134 share price and it's not the $94 analyst target. It's the number I'd actually pay: $60–80. Here's how I got there — and the method matters more than the answer, because you can run it on any stock.

Step 1 — Project the business forward. I use a stock analyzer that takes my own assumptions for the next 10 years — revenue growth, profit margin, free-cash-flow margin, and the exit multiples (P/E and P/FCF) I think the business deserves down the road. I deliberately keep these conservative; for a turnaround like Intel, optimistic inputs are how you talk yourself into overpaying.

Step 2 — Anchor it to the return I require. The tool then discounts that 10-year projection back to today using my desired annual return. This is the key move: instead of asking "what might Intel be worth someday," it asks "what would I have to pay right now to earn the return I want, if my assumptions hold?" That flips valuation into a discipline — the price comes to me, I don't chase it.

Run with conservative inputs, that math lands me in the $60–80 range.

Step 3 — The one thing the model misses (and how I handle it). Honesty matters here: this tool values the business but doesn't account for the balance sheet. Intel carries more debt than cash — that's what "Enterprise Value above Market Cap" signals — so I adjust by leaning toward the low end of my range. A company funding an expensive turnaround on borrowed money deserves to be valued with the debt in mind, not ignored.

The confluence check. What gives me extra confidence isn't more math — it's that the chart agrees. When Intel gapped up on April earnings, it launched from about $65. That level is the floor the entire 2026 breakout was built on, and it sits right inside my fundamental range. An independent third-party model landed near $67 as well. Three different lenses, one zone. That's the kind of agreement I want before I commit capital.

So where does that leave us?

The stock is trading well above even the analysts who like it. For me to be a buyer, Intel would need to come back to a price that pays me for the business that exists today — not the one the market is hoping it becomes. Until then, I watch and wait.

I've made my call: Intel is overvalued, and I'm waiting for $60–80. This section is where I stay honest about how that call could go wrong — because the fastest way to blow up as an investor is to fall in love with your own thesis.

Risk 1 — The debt makes this a rate-sensitive turnaround. Intel is funding Foundry with borrowed money, and it's burning cash rather than generating it (negative free cash flow, more debt than cash on hand). That's manageable in a cheap-money world. It's harder in this one. With rates higher for longer (see The Market), every dollar Intel borrows to keep its fabs running costs more to service — and a company that can't yet self-fund its turnaround is exactly the kind of business that feels higher-for-longer rates the most. This is the balance-sheet risk my valuation tool doesn't capture, which is why I lean toward the low end of my range.

Risk 2 — Washington has its thumb on the scale. This one cuts both ways, and that's exactly why it belongs here. Intel is backed by the U.S. government and championed publicly by the President — it's the only American company that both designs and builds leading-edge chips on U.S. soil, which makes it a strategic national asset, not just a stock. For the company, that's real downside protection: subsidies, political will, and a buyer-of-last-resort feel. But for my bearish stance, it's the single biggest risk. A stock that powerful people are actively determined to see succeed may simply not be allowed to fall to the price my spreadsheet says it's worth. Fundamentals set fair value; politics can keep a stock above it for a long time.

Risk 3 — I could just be early, which looks a lot like being wrong. The customer news keeps mounting — reported interest from Apple, Nvidia, and Google. If even one of those becomes a signed, named, at-scale foundry customer, the bull thesis stops being a hope and starts being a fact, and the stock may never revisit my range. The cost of discipline is real: by refusing to chase, I accept that I might watch Intel run from $134 to $180 and never get my entry. I'm okay with that trade-off — but I'd be lying if I pretended it wasn't a risk.

What would change my mind (the tripwires I'm watching):

If those break Intel's way, I won't dig in — I'll update my number. A thesis you can't change isn't a thesis, it's a belief.

Each week I break down a real options trade idea — not a position I'm telling you I hold, just a setup I find interesting and a walkthrough of how I'd think about structuring it. The goal is to teach the mechanics, so even if you've never traded an option, you can follow the logic. (Educational only — not a recommendation. See the disclaimer.)

The idea: a bullish bet on Amazon (AMZN trading ~$244)

What a "call option" actually is. A call option is a contract that gives you the right — but not the obligation — to buy 100 shares of a stock at a fixed price (the "strike") before a set expiration date. You pay a fee up front for that right, called the premium. If the stock climbs above your strike, your right to buy cheap becomes valuable. If it doesn't, the most you can lose is the premium you paid. Think of it like putting a small deposit down to lock in today's price on something you expect to get more expensive — if you're right, you profit from the difference; if you're wrong, you only lose the deposit.

In this case: the setup is to pay $1,660 for the right to buy 100 shares of Amazon at $250 anytime before September 18. Capped downside, uncapped upside — that's the appeal of buying a call.

Breakeven, and why you don't need to hit it. On paper, Amazon would need to be above $266.60 by expiration for this to pay off if held all the way — about 9% above today's price, and still below the May all-time high near $278. But this idea isn't built to hold to expiration. If the stock rises and volatility picks up over the next few weeks, the option gains value while time is still on its side, and it can be sold for a profit well before Amazon ever reaches $266.60. Breakeven-at-expiration and profit-before-expiration are two different things.

The Greeks, in plain English (these are just risk measures):

Why this setup is interesting:

The plan — and a deliberate choice about earnings. The idea uses a September expiration but is built to close before the July 30 earnings report. The logic: capture the rise in volatility heading into earnings, without gambling on the report itself. Earnings can gap a stock either direction, and the volatility that inflates an option beforehand often collapses right after — which can sink a call even when the stock rises. So the disciplined version of this idea takes the volatility runway and steps aside before the dice roll.

The honest risks: this idea can lose 100% of its premium ($1,660) if Amazon stalls or drifts sideways. Time decay works against it every day. And if the exit gets mistimed and the position is held into July 30, it's exposed to exactly the earnings gap and volatility crush the plan is trying to avoid. Any trade like this should be sized as a defined-risk bet you can afford to lose in full.

The biggest lesson from researching Intel had nothing to do with chips. It was watching the stock run to $134 on partnership headlines while my own analysis kept pointing to $60–80 — and sitting with how uncomfortable that gap feels.

Here's what clicked: the market prices hope in real time. The moment news broke about possible Apple, Nvidia, and Google deals, the stock jumped — long before any of those wins showed up in actual revenue or proved the foundry can turn a profit. The fundamentals hadn't changed. The story had. And the story moved the price.

That taught me something about the discipline this newsletter is built on. Being a value-minded investor doesn't mean you're never wrong — it means you're often early, and early can look identical to wrong for a long time. If I refuse to chase, I have to accept I might watch Intel keep climbing without me. That's the cost of waiting for a price that pays me for the business as it exists today, not the one the market is hoping it becomes.

So my takeaway isn't "I was right and the market is irrational." It's quieter than that: separate the story from the numbers, respect that narrative can move a stock further and longer than you'd expect, and let your process — not the headlines — decide what you'll pay.

Seven has always meant completeness. In the oldest stories, the world was finished in seven days — and the seventh was the day to step back and take in the whole of it. That's the promise of this letter: seven sections, one complete and careful look at a company, every single week. No shortcuts, no half-finished thinking — the whole picture, with precision, laid out plainly enough that anyone can follow it.

This week, completeness meant sitting with an uncomfortable gap between what a stock costs and what it's worth — and choosing patience over the crowd.

See you next Sunday.

— 7even Seven — 001

Disclaimer: SVN Research is educational commentary and reflects personal opinions only. It is not financial, investment, legal, or tax advice, and nothing here is a recommendation to buy or sell any security. Markets are risky and you can lose money. Always do your own research and consider consulting a licensed financial professional before making any investment decision.